INHIBITOREN DER MICRO-RNA 22

European patent · EP3765619 · In force

Register entry

Publication number
EP3765619
Application number
EP19768368
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Mar 14, 2019
Published
Jan 20, 2021
Granted
Oct 9, 2024
Protection ends at the latest
Mar 13, 2039
Next annual fee due
Mar 31, 2027
IPC classes
C12N 15/113 (2010.01)
A61K 31/713 (2006.01)
Priority
US 201862642934 P 14.03.2018
PCT application
PCT/US2019/022351 14.03.2019
PCT publication
WO2019/178411 19.09.2019
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Apr 1, 2026

    Change

    Published in Swissreg on 01.04.2026

  2. Aug 20, 2025

    Change

    Published in Swissreg on 20.08.2025

  3. Apr 1, 2025

    Change

    Published in Swissreg on 01.04.2025

  4. Jan 3, 2025

    Agent entered

    Representative
    VALIPAT, c/o BOVARD LTD, Optingenstrasse 16, 3013 Bern

    Published in Swissreg on 03.01.2025

  5. Oct 9, 2024

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 09.10.2024

Parties

Holder

Beth Israel Deaconess Medical Center

Boston, MA 02215, US

Aalborg University

Fredrik Bajers Vej 5, 9100 Aalborg, DK

Agent

VALIPAT c/o BOVARD LTD

Optingenstrasse 16, 3013 Bern

Inventor

PANDOLFI, Pier, Paolo

Boston, MA 02215, US

PANELLA, Riccardo

Boston, MA 02215, US

KAUPPINEN, Sakari

9100 Aalborg, DK

PETRI, Andreas

9100 Aalborg, DK

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.